FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pyrrol derivatives of formula (1): 
or a pharmaceutically acceptable salt thereof wherein the values A, R1-R3, n are specified in clause 1 of the patent claim.
EFFECT: compounds (1) inhibit activity against the interleukin IL-6 production that allows using them both in pharmaceutical compositions, and in a prophylactic drug for ocular inflammatory disease.
23 cl, 2 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL INDOLE DERIVATIVES HAVING IκB KINASE β INHIBITING ACTIVITY | 2008 |
|
RU2470918C2 |
| NEW 1,2-DIHYDROQUINOLINE DERIVATIVES POSSESSING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY | 2007 |
|
RU2485104C2 |
| NOVEL INDOLE DERIVATIVE CONTAINING CARBAMOYL GROUP, UREIDE GROUP AND SUBSTITUTED OXY GROUP | 2009 |
|
RU2503661C2 |
| ANTAGONISTS OF THROMBIN RECEPTOR | 2005 |
|
RU2408594C2 |
| USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
| NOVEL PYRROLE DERIVATIVE HAVING AS SUBSTITUTES UREIDE GROUP, AMINOCARBONYL GROUP AND BICYCLIC GROUP, OPTIONALLY SUBSTITUTED | 2009 |
|
RU2500669C2 |
| PARA-TERPHENYL COMPOUNDS, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PHARMACEUTICAL COMPOSITION (VERSIONS) | 1997 |
|
RU2200730C2 |
| PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
| METHOD FOR TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY ACTIVITY OF KINASE BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R | 2010 |
|
RU2625835C2 |
| SUBSTITUTED ETHERS OF 5-HYDROXY-1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINMENT AND APPLICATION | 2007 |
|
RU2344817C1 |
